Victor Tong
Victor Tong is Partner at Decheng Capital and a board member of AccuraGen, Cellares, Take2 Health, LevitasBio, Cue Health, EpimAb Biotherapeutics, GenapSys, Mammoth Biosciences, and Sema4.
Genapsys is a company developing DNA sequencing technologies and systems founded in 2010 by Hesaam Esfandyarpour.
Cue Health is a San Diego-based medical device company working to track health information at the molecular level.
EpimAb Biotherapeutics is a bi-specific Antibodies founded in 2015 by Chengbin Wu.
Cellares is a biotechnology and cell therapy company founded in 2019 by Fabian Gerlinghaus, Alex Pesch, and Omar Kurdi.
AccuraGen is a Menlo Park, California-based medical diagnostics company developing liquid biopsy technology for cancer treatment.
Mount Sinai Genomics is a Connecticut-based medical genetics practice at the Mount Sinai Health System.
LevitasBio specializes in cellular analysis using magnetic levitation.
Take2 Health is a healthcare startup that builds platforms for the biomedical sciences and informatics fields.